Positron to Exhibit at the American Society of Nuclear Cardiology 16th Annual Scientific Session

INDIANAPOLIS--(BUSINESS WIRE)-- Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, will be exhibiting at the 16th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), to be held in Denver, CO, September 8th through 11th, 2011 at the Colorado Convention Center.

“This year’s ASNC conference serves as a key industry venue to assert Positron’s message to the nuclear cardiac imaging community,” states Patrick G. Rooney, CEO of Positron. “The solutions we are currently investing in will help solve several challenges concerning the supply and availability of cardiac PET and SPECT radiopharmaceuticals. These challenges further justify Positron’s approach to secure future medical isotope production for cardiac PET imaging through our cyclotron project. Our business model supports offering a total solution for the nuclear cardiology industry; with our product portfolio, generator plans and future isotope production, Positron is ideally positioned to support the industry’s demands and needs. Positron will be the long-term solutions provider for the cardiology imaging community. We are excited about the future and look forward to this being our most productive conference to date.”

The American Society of Nuclear Cardiology (ASNC) is a professional not-for-profit organization, international in scope, which provides its members with a variety of continuing medical education programs related to nuclear cardiology and cardiovascular imaging. Additionally, ASNC promotes accreditation and certification in nuclear cardiology and is the principal advocacy voice for the profession.

ASNC was founded in 1993 by a group of nuclear cardiology specialists in a professional society dedicated solely to the needs of those who perform nuclear medical procedures. Currently, there are more than 4,700 ASNC members in good standing. ASNC is an individual member society comprised of physicians, scientists, technologists, and other personnel who work in the nuclear cardiology field. ASNC is truly international in scope with several hundred members residing in countries other than the United States.

About Positron: Positron Corporation is a leading molecular imaging company providing innovative nuclear medicine technologies and services that are reshaping the field of nuclear cardiology. Through proprietary PET imaging systems and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine. Positron has gained significant traction in a diverse industry and continues their strong commitment to excellence and advancing cardiac imaging solutions. More information about Positron is available at www.positron.com.

Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Positron assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as “Risk Factors” in our filings with the Securities and Exchange Commission.



CONTACT:

Positron Corporation
Patrick G. Rooney
Chief Executive Officer
866.613.7587

KEYWORDS:   United States  North America  Illinois

INDUSTRY KEYWORDS:   Health  Cardiology  Clinical Trials  Hospitals  Medical Devices  Oncology  Radiology  Other Health  Research  Science

MEDIA:

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.